Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Rebillard, A; Tekpli, X; Meurette, O et al.

Cisplatin-induced apoptosis involves membrane fluidification via inhibition of NHE1 in human colon cancer cells

Cancer Res. Bd. 67. 2007 S. 7865-7874


Nagel, G; Wiewrodt, D; Perneczky, A et al.

Comparing MGMT activity and promoter methylation in glioblastomas as predictive tools

Naunyn Schmiedebergs Arch Pharmacol. Bd. 375. 2007 S. 85


Loos, M; Petry, F; Colomb, M et al.

Complement activation and innate immunity.

Immunobiology. Bd. 212. H. 4-5. 2007 S. 229-32


Bopp, T; Becker, C; Klein, M et al.

Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression.

J Exp Med. Bd. 204. H. 6. 2007 S. 1303-1310


Carmo, H; Brulport, M; Hermes, M et al.

CYP2D6 increases toxicity of the designer drug 4-methylthioamphetamine (4-MTA)

Toxicology. Bd. 229. 2007 S. 236-244


Wiese, E; Maurer, S; Steige, G et al.

Decontamination of a barrier facility using microisolator cages and provisional partitioning.

Lab Anim (NY). Bd. 36. H. 7. 2007 S. 31-5



Torzewski, M; Ochsenhirt, V; Kleschyov, AL et al.

Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

Arterioscler Thromb Vasc Biol. Bd. 27. H. 4. 2007 S. 850-7



Tuettenberg, A; Schmitt, E; Knop, J et al.

Dendritic cell-based immunotherapy of malignant melanoma: success and limitations

J Dtsch Dermatol Ges. Bd. 5. H. 3. 2007 S. 190-6